SLC22A2 Gene

HGNC Family Solute carriers (SLC)
Name solute carrier family 22 (organic cation transporter), member 2
Description Polyspecific organic cation transporters in the liver, kidney, intestine, and other organs are critical for elimination of many endogenous small organic cations as well as a wide array of drugs and environmental toxins. This gene is one of three similar cation transporter genes located in a cluster on chromosome 6. The encoded protein contains twelve putative transmembrane domains and is a plasma integral membrane protein. It is found primarily in the kidney, where it may mediate the first step in cation reabsorption. [provided by RefSeq, Jul 2008]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nSLC22A2, which encodes the organic cation transporter 2 (OCT2), is a membrane carrier predominantly expressed in renal proximal tubular cells. It plays a central role in the uptake and secretion of endogenous organic cations such as creatinine, amino acids, and other metabolites, thereby contributing to renal clearance. Genetic analyses have revealed multiple variants that affect OCT2’s transport activity and expression, underscoring its importance in normal renal function and in the variation of serum biomarkers used to assess kidney function."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "8"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its endogenous substrates, OCT2 mediates the cellular uptake of several xenobiotics and therapeutic drugs. Its transport function is critical for the renal handling of platinum‐based anticancer agents such as oxaliplatin, cisplatin, and picoplatin – thereby modulating both antitumor efficacy and drug‐induced nephrotoxicity. Similarly, OCT2 is implicated in the pharmacokinetics of metformin and in the transport of other organic cations including agmatine, ranitidine, rhodamine 123, as well as key biogenic amines such as asymmetric dimethylarginine and L‐arginine. Studies demonstrate that common genetic polymorphisms in SLC22A2 can alter OCT2 transport activity, contributing to individual differences in drug disposition, efficacy, and side effect profiles."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "9", "end_ref": "25"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nOCT2 function is further modulated by post‐translational modifications, oligomerization, and transcriptional as well as epigenetic regulatory mechanisms, which can affect its plasma membrane targeting and transport kinetics. Such regulation not only influences the susceptibility to drug-induced toxicities (for example, cisplatin nephrotoxicity) but also appears to impact chemoresistance profiles in cancer, with changes in OCT2 expression being linked to altered intracellular drug accumulation. Moreover, several studies have implicated microRNA-mediated regulation and promoter polymorphisms as factors altering OCT2 expression levels, thereby contributing to inter‐individual variations in both drug response and adverse event risk."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "26", "end_ref": "29"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Maya K Leabman, Conrad C Huang, Michiko Kawamoto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenetics (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/00008571-200207000-00007"}], "href": "https://doi.org/10.1097/00008571-200207000-00007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12142729"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12142729"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Ibrahim Cetinkaya, Giuliano Ciarimboli, Gülay Yalçinkaya, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of human organic cation transporter hOCT2 by PKA, PI3K, and calmodulin-dependent kinases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Renal Physiol (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajprenal.00251.2002"}], "href": "https://doi.org/10.1152/ajprenal.00251.2002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12388397"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12388397"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Dirk Gründemann, Christian Hahne, Reinhard Berkels, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Agmatine is efficiently transported by non-neuronal monoamine transporters extraneuronal monoamine transporter (EMT) and organic cation transporter 2 (OCT2)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Pharmacol Exp Ther (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/jpet.102.044404"}], "href": "https://doi.org/10.1124/jpet.102.044404"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12538837"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12538837"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Hiromi Fukushima-Uesaka, Keiko Maekawa, Shogo Ozawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Fourteen novel single nucleotide polymorphisms in the SLC22A2 gene encoding human organic cation transporter (OCT2)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Drug Metab Pharmacokinet (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2133/dmpk.19.239"}], "href": "https://doi.org/10.2133/dmpk.19.239"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15499192"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15499192"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Katrin Susanne Lips, Christopher Volk, Bernhard Matthias Schmitt, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Polyspecific cation transporters mediate luminal release of acetylcholine from bronchial epithelium."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Respir Cell Mol Biol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1165/rcmb.2004-0363OC"}], "href": "https://doi.org/10.1165/rcmb.2004-0363OC"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15817714"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15817714"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Giuliano Ciarimboli, Thomas Ludwig, Detlef Lang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Pathol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/S0002-9440(10)61234-5"}], "href": "https://doi.org/10.1016/S0002-9440(10"}, {"type": "t", "text": "61234-5) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16314463"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16314463"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Ryan M Pelis, Wendy M Suhre, Stephen H Wright "}, {"type": "b", "children": [{"type": "t", "text": "Functional influence of N-glycosylation in OCT2-mediated tetraethylammonium transport."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Renal Physiol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajprenal.00462.2005"}], "href": "https://doi.org/10.1152/ajprenal.00462.2005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16368738"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16368738"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Anna Köttgen, Cristian Pattaro, Carsten A Böger, et al. "}, {"type": "b", "children": [{"type": "t", "text": "New loci associated with kidney function and chronic kidney disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng.568"}], "href": "https://doi.org/10.1038/ng.568"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20383146"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20383146"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Shuzhong Zhang, Katherine S Lovejoy, James E Shima, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Organic cation transporters are determinants of oxaliplatin cytotoxicity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-06-0769"}], "href": "https://doi.org/10.1158/0008-5472.CAN-06-0769"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16951202"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16951202"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Ryan M Pelis, Xiaohong Zhang, Yodying Dangprapai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cysteine accessibility in the hydrophilic cleft of human organic cation transporter 2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M606561200"}], "href": "https://doi.org/10.1074/jbc.M606561200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16990275"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16990275"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Eriko Shikata, Rei Yamamoto, Hiroshi Takane, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Hum Genet (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10038-006-0087-0"}], "href": "https://doi.org/10.1007/s10038-006-0087-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17111267"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17111267"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Ho-Jin Kang, Im-Sook Song, Ho Jung Shin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification and functional characterization of genetic variants of human organic cation transporters in a Korean population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Drug Metab Dispos (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/dmd.106.013581"}], "href": "https://doi.org/10.1124/dmd.106.013581"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17220237"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17220237"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "I S Song, H J Shin, E J Shim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic variants of the organic cation transporter 2 influence the disposition of metformin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Pharmacol Ther (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/clpt.2008.61"}], "href": "https://doi.org/10.1038/clpt.2008.61"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18401339"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18401339"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Ken Ogasawara, Tomohiro Terada, Hideyuki Motohashi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Analysis of regulatory polymorphisms in organic ion transporter genes (SLC22A) in the kidney."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Hum Genet (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10038-008-0288-9"}], "href": "https://doi.org/10.1007/s10038-008-0288-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18414781"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18414781"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Zhi-Jun Wang, Ophelia Q P Yin, Brian Tomlinson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenet Genomics (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/FPC.0b013e328302cd41"}], "href": "https://doi.org/10.1097/FPC.0b013e328302cd41"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18551044"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18551044"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Ying Chen, Shuanglian Li, Chaline Brown, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenet Genomics (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/FPC.0b013e32832cc7e9"}], "href": "https://doi.org/10.1097/FPC.0b013e32832cc7e9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19483665"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19483665"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "K K Filipski, R H Mathijssen, T S Mikkelsen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Contribution of organic cation transporter 2 (OCT2) to cisplatin-induced nephrotoxicity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Pharmacol Ther (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/clpt.2009.139"}], "href": "https://doi.org/10.1038/clpt.2009.139"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19625999"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19625999"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "H Burger, A Zoumaro-Djayoon, A W M Boersma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Pharmacol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1476-5381.2009.00569.x"}], "href": "https://doi.org/10.1111/j.1476-5381.2009.00569.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20067471"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20067471"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Tate N Winter, William F Elmquist, Carolyn A Fairbanks "}, {"type": "b", "children": [{"type": "t", "text": "OCT2 and MATE1 provide bidirectional agmatine transport."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Pharm (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/mp100180a"}], "href": "https://doi.org/10.1021/mp100180a"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21128598"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21128598"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Sabine Brast, Alexander Grabner, Sonja Sucic, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The cysteines of the extracellular loop are crucial for trafficking of human organic cation transporter 2 to the plasma membrane and are involved in oligomerization."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FASEB J (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1096/fj.11-180679"}], "href": "https://doi.org/10.1096/fj.11-180679"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22085643"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22085643"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Jing Zhang, Wen Zhou "}, {"type": "b", "children": [{"type": "t", "text": "Ameliorative effects of SLC22A2 gene polymorphism 808 G/T and cimetidine on cisplatin-induced nephrotoxicity in Chinese cancer patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Food Chem Toxicol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.fct.2012.03.077"}], "href": "https://doi.org/10.1016/j.fct.2012.03.077"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22525860"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22525860"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Im-Sook Song, Do Yup Lee, Min-Hye Shin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Pharmacogenetics meets metabolomics: discovery of tryptophan as a new endogenous OCT2 substrate related to metformin disposition."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0036637"}], "href": "https://doi.org/10.1371/journal.pone.0036637"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22590580"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22590580"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Linda Tarasova, Ineta Kalnina, Kristine Geldnere, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association of genetic variation in the organic cation transporters OCT1, OCT2 and multidrug and toxin extrusion 1 transporter protein genes with the gastrointestinal side effects and lower BMI in metformin-treated type 2 diabetes patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenet Genomics (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/FPC.0b013e3283561666"}], "href": "https://doi.org/10.1097/FPC.0b013e3283561666"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22735389"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22735389"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Elodie Jouan, Marc Le Vee, Claire Denizot, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The mitochondrial fluorescent dye rhodamine 123 is a high-affinity substrate for organic cation transporters (OCTs) 1 and 2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Fundam Clin Pharmacol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1472-8206.2012.01071.x"}], "href": "https://doi.org/10.1111/j.1472-8206.2012.01071.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22913740"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22913740"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Ying Wang, Ji-Ye Yin, Xiang-Ping Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The association of transporter genes polymorphisms and lung cancer chemotherapy response."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0091967"}], "href": "https://doi.org/10.1371/journal.pone.0091967"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24643204"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24643204"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Chen-Yue Qian, Yi Zheng, Ying Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Associations of genetic polymorphisms of the transporters organic cation transporter 2 (OCT2), multidrug and toxin extrusion 1 (MATE1), and ATP-binding cassette subfamily C member 2 (ABCC2) with platinum-based chemotherapy response and toxicity in non-small cell lung cancer patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Chin J Cancer (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s40880-016-0145-8"}], "href": "https://doi.org/10.1186/s40880-016-0145-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27590272"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27590272"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Di Huang, Chuangyuan Wang, Yingjie Duan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Targeting Oct2 and P53: Formononetin prevents cisplatin-induced acute kidney injury."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Toxicol Appl Pharmacol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.taap.2017.04.013"}], "href": "https://doi.org/10.1016/j.taap.2017.04.013"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28414026"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28414026"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Kelly Gaudelot, Jean-Baptiste Gibier, Nicolas Pottier, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Targeting miR-21 decreases expression of multi-drug resistant genes and promotes chemosensitivity of renal carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/1010428317707372"}], "href": "https://doi.org/10.1177/1010428317707372"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28714373"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28714373"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Aishwarya Ravindran, Gaurav Goyal, Ronald S Go, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Rosai-Dorfman Disease Displays a Unique Monocyte-Macrophage Phenotype Characterized by Expression of OCT2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Surg Pathol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/PAS.0000000000001617"}], "href": "https://doi.org/10.1097/PAS.0000000000001617"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33177341"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33177341"}]}]}]}
Synonyms OCT2
Proteins S22A2_HUMAN
NCBI Gene ID 6582
API
Download Associations
Predicted Functions View SLC22A2's ARCHS4 Predicted Functions.
Co-expressed Genes View SLC22A2's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View SLC22A2's ARCHS4 Predicted Functions.

Functional Associations

SLC22A2 has 4,572 functional associations with biological entities spanning 8 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 107 datasets.

Click the + buttons to view associations for SLC22A2 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles tissues with high or low expression of SLC22A2 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of SLC22A2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray tissue samples with high or low expression of SLC22A2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset.
BioGPS Cell Line Gene Expression Profiles cell lines with high or low expression of SLC22A2 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset.
BioGPS Human Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of SLC22A2 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset.
BioGPS Mouse Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of SLC22A2 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset.
Carcinogenome Chemical Perturbation Carcinogenicity Signatures small molecule perturbations changing expression of SLC22A2 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of SLC22A2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
CCLE Cell Line Gene Expression Profiles cell lines with high or low expression of SLC22A2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
CellMarker Gene-Cell Type Associations cell types associated with SLC22A2 gene from the CellMarker Gene-Cell Type Associations dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of SLC22A2 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of SLC22A2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
ChEA Transcription Factor Targets 2022 transcription factors binding the promoter of SLC22A2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of SLC22A2 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores cellular components containing SLC22A2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 cellular components containing SLC22A2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores cellular components co-occuring with SLC22A2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with SLC22A2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of SLC22A2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
COSMIC Cell Line Gene Mutation Profiles cell lines with SLC22A2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset.
CTD Gene-Chemical Interactions chemicals interacting with SLC22A2 gene/protein from the curated CTD Gene-Chemical Interactions dataset.
CTD Gene-Disease Associations diseases associated with SLC22A2 gene/protein from the curated CTD Gene-Disease Associations dataset.
dbGAP Gene-Trait Associations traits associated with SLC22A2 gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset.
DepMap CRISPR Gene Dependency cell lines with fitness changed by SLC22A2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
DISEASES Experimental Gene-Disease Association Evidence Scores diseases associated with SLC22A2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset.
DISEASES Experimental Gene-Disease Association Evidence Scores 2025 diseases associated with SLC22A2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores diseases co-occuring with SLC22A2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with SLC22A2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
DisGeNET Gene-Disease Associations diseases associated with SLC22A2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
DisGeNET Gene-Phenotype Associations phenotypes associated with SLC22A2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
DrugBank Drug Targets interacting drugs for SLC22A2 protein from the curated DrugBank Drug Targets dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at SLC22A2 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of SLC22A2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of SLC22A2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
ESCAPE Omics Signatures of Genes and Proteins for Stem Cells PubMedIDs of publications reporting gene signatures containing SLC22A2 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset.
GAD Gene-Disease Associations diseases associated with SLC22A2 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.
GAD High Level Gene-Disease Associations diseases associated with SLC22A2 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset.
GDSC Cell Line Gene Expression Profiles cell lines with high or low expression of SLC22A2 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with SLC22A2 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing SLC22A2 from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Diseases disease perturbations changing expression of SLC22A2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of SLC22A2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations kinase perturbations changing expression of SLC22A2 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of SLC22A2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations transcription factor perturbations changing expression of SLC22A2 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Viral Infections virus perturbations changing expression of SLC22A2 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset.
GO Biological Process Annotations 2015 biological processes involving SLC22A2 gene from the curated GO Biological Process Annotations 2015 dataset.
GO Biological Process Annotations 2023 biological processes involving SLC22A2 gene from the curated GO Biological Process Annotations 2023 dataset.
GO Biological Process Annotations 2025 biological processes involving SLC22A2 gene from the curated GO Biological Process Annotations2025 dataset.
GO Cellular Component Annotations 2015 cellular components containing SLC22A2 protein from the curated GO Cellular Component Annotations 2015 dataset.
GO Cellular Component Annotations 2023 cellular components containing SLC22A2 protein from the curated GO Cellular Component Annotations 2023 dataset.
GO Cellular Component Annotations 2025 cellular components containing SLC22A2 protein from the curated GO Cellular Component Annotations 2025 dataset.
GO Molecular Function Annotations 2015 molecular functions performed by SLC22A2 gene from the curated GO Molecular Function Annotations 2015 dataset.
GO Molecular Function Annotations 2023 molecular functions performed by SLC22A2 gene from the curated GO Molecular Function Annotations 2023 dataset.
GO Molecular Function Annotations 2025 molecular functions performed by SLC22A2 gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of SLC22A2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of SLC22A2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of SLC22A2 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
GWAS Catalog SNP-Phenotype Associations phenotypes associated with SLC22A2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset.
GWAS Catalog SNP-Phenotype Associations 2025 phenotypes associated with SLC22A2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.
GWASdb SNP-Disease Associations diseases associated with SLC22A2 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset.
GWASdb SNP-Phenotype Associations phenotypes associated with SLC22A2 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset.
Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles cell lines with high or low expression of SLC22A2 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset.
HMDB Metabolites of Enzymes interacting metabolites for SLC22A2 protein from the curated HMDB Metabolites of Enzymes dataset.
HPA Tissue Gene Expression Profiles tissues with high or low expression of SLC22A2 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset.
HPA Tissue Protein Expression Profiles tissues with high or low expression of SLC22A2 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset.
HPA Tissue Sample Gene Expression Profiles tissue samples with high or low expression of SLC22A2 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset.
HuGE Navigator Gene-Phenotype Associations phenotypes associated with SLC22A2 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.
InterPro Predicted Protein Domain Annotations protein domains predicted for SLC22A2 protein from the InterPro Predicted Protein Domain Annotations dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of SLC22A2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Mouse Transcription Factor Targets 2025 transcription factors regulating expression of SLC22A2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of SLC22A2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
KEGG Pathways 2026 pathways involving SLC22A2 protein from the KEGG Pathways 2026 dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of SLC22A2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of SLC22A2 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures small molecule perturbations changing expression of SLC22A2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset.
LINCS L1000 CMAP CRISPR Knockout Consensus Signatures gene perturbations changing expression of SLC22A2 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset.
LOCATE Curated Protein Localization Annotations cellular components containing SLC22A2 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset.
LOCATE Predicted Protein Localization Annotations cellular components predicted to contain SLC22A2 protein from the LOCATE Predicted Protein Localization Annotations dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by SLC22A2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
MiRTarBase microRNA Targets microRNAs targeting SLC22A2 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of SLC22A2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
MPO Gene-Phenotype Associations phenotypes of transgenic mice caused by SLC22A2 gene mutations from the MPO Gene-Phenotype Associations dataset.
MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations gene perturbations changing expression of SLC22A2 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset.
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles drug perturbations changing expression of SLC22A2 gene from the NIBR DRUG-seq U2OS MoA Box dataset.
Pathway Commons Protein-Protein Interactions interacting proteins for SLC22A2 from the Pathway Commons Protein-Protein Interactions dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of SLC22A2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations gene perturbations changing expression of SLC22A2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PFOCR Pathway Figure Associations 2023 pathways involving SLC22A2 protein from the PFOCR Pathway Figure Associations 2023 dataset.
PFOCR Pathway Figure Associations 2024 pathways involving SLC22A2 protein from the Wikipathways PFOCR 2024 dataset.
Reactome Pathways 2014 pathways involving SLC22A2 protein from the Reactome Pathways dataset.
Reactome Pathways 2024 pathways involving SLC22A2 protein from the Reactome Pathways 2024 dataset.
Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles cell types and tissues with high or low DNA methylation of SLC22A2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at SLC22A2 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of SLC22A2 gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of SLC22A2 gene from the RummaGEO Gene Perturbation Signatures dataset.
SynGO Synaptic Gene Annotations synaptic terms associated with SLC22A2 gene from the SynGO Synaptic Gene Annotations dataset.
TargetScan Predicted Conserved microRNA Targets microRNAs regulating expression of SLC22A2 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset.
TargetScan Predicted Nonconserved microRNA Targets microRNAs regulating expression of SLC22A2 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset.
TCGA Signatures of Differentially Expressed Genes for Tumors tissue samples with high or low expression of SLC22A2 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores tissues with high expression of SLC22A2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of SLC22A2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores tissues with high expression of SLC22A2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores tissues co-occuring with SLC22A2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with SLC22A2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.
WikiPathways Pathways 2014 pathways involving SLC22A2 protein from the Wikipathways Pathways 2014 dataset.
WikiPathways Pathways 2024 pathways involving SLC22A2 protein from the WikiPathways Pathways 2024 dataset.